Answers are grounded in this paper and cite their sources.
OBJECTIVE: This study investigated the impact of cigarette smoke extract (CSE) on BEAS-2B bronchial epithelial cells, focusing on whether it induces pyroptosis via the ROS/NLRP3/GSDMD pathway and how NAC protects these cells from pyroptosis. METHODS: BEAS-2B cells were treated with varying CSE concentrations, and cellular damage was evaluated via PI staining and release of ROS and LDH. Cellular morphology alterations were examined by immunohistochemistry, and IL-18 and IL-1β release were measured by ELISA. Western blot analysis was used to assess expression of proteins linked to pyroptosis, including ASC, NLRP3, cleaved-caspase-1, GSDMD-N, and IL-1β. Caspase-1 and GSDMD inhibitors were utilized to elucidate the underlying mechanisms. RESULTS: Following CSE treatment, bronchial epithelial cells demonstrated inflammatory infiltration and membrane rupture and increased ROS, NLRP3, cleaved-caspase-1, GSDMD-N, IL-18, and IL-1β expression. Treatment with caspase-1 and GSDMD inhibitors decreased expression of these markers, as expected. Interestingly, NAC treatment reduced the expression of these proteins compared to the CSE group, suggesting a protective role against pyroptosis through inhibition of the ROS/NLRP3/GSDMD pathway. CONCLUSION: The study shows that CSE triggers pyroptosis in COPD via the ROS/NLRP3/GSDMD pathway, with NAC offering antioxidative protection. These findings enhance understanding of AECOPD pathophysiology and support NAC's therapeutic role in treatment.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: